Background. Over the last few years, numerous reviews and studies have awarded articaine hydrochloride local anaesthetic (LA) a superior reputation, with outcomes of different studies demonstrating a general tendency for articaine hydrochloride to outperform lidocaine hydrochloride for dental treatment. Nevertheless, there seems to be no clear agreement on which LA solution is more efficacious in dental treatment for children. There is no previous publication systematically reviewing and summarising the current best evidence with respect to the success rates of LA solutions in children. Aims. To evaluate the available evidence on the efficacy of lidocaine and articaine, used in paediatric dentistry. Original research studies that compared articaine with lidocaine for dental treatment in children were included. Methodological quality assessment and assessment of risk of bias were carried out for each of the included studies. Results. Electronic searching identified 525 publications. Following the primary and secondary assessment process, six randomised controlled trials (RCT) were included in the final analysis. There was no difference between patient selfreported pain between articaine and lidocaine during treatment procedures (SMD = 0.06, P-value = 0.614), and no difference in the occurrence of adverse events between articaine and lidocaine injections following treatment in paediatric patients (RR = 1.10, P-value = 0.863). Yet, patients reported significantly less pain post-procedure following articaine injections (SMD = 0.37, P-value = 0.013). Substantial heterogeneity was noted in the reporting of outcomes among studies, with the overall quality of majority of studies being at high risk of bias. Conclusions. There is low quality evidence suggesting that both articaine as infiltration and lidocaine IAD nerve blocks presented the same efficacy when used for routine dental treatments, with no difference between patient self-reported pain between articaine and lidocaine during treatment procedures. Yet, significantly less pain post-procedure was reported following articaine injections. There was no difference in the occurrence of adverse events between articaine and lidocaine injections following treatment in paediatric patients.
Introduction
Local anaesthetic (LA) solutions have been utilised in clinical dentistry to alleviate or eliminate pain associated with invasive procedures as early as the 19th Century 1 . Since then, a broad spectrum of LA has been progressively developing. Lidocaine hydrochlorite was first clinically available in 1948 and has since remained the most widely marketed and used amide LA in dentistry 2, 3 . The value and safety of this LA drug has been proved through clinical use and research to be efficacious, with minimal toxicity and low reports of allergic reactions. Thus, it is the 'gold standard' to which all new LA is compared 1 . Due to the perception that it has enhanced anaesthetic efficacy, articaine hydrochloride has been conferred a superior reputation by numerous reviews and studies 4 . The outcomes of different studies revealed a general tendency for articaine hydrochloride to outperform the lidocaine hydrochloride in dentistry [4] [5] [6] [7] [8] [9] . Yet, there seems to be no clear agreement on which LA solution is more efficacious in dental treatment for children.
A search of the literature revealed no previous publication systematically reviewing and summarising the current state of evidence with respect to the success rates of LA solutions in children. The present systematic review was carried out to address this gap in the literature. The aims of the review was to assess the efficacy of 2% lidocaine hydrochloride and 4% articaine hydrochloride (both with epinephrine as vasoconstrictor), and to compare the outcomes, advantages and harms of their use in the provision of pulpal and soft tissue analgesia in clinical paediatric dentistry.
Material and methods
This review was designed, performed and reported in adherence to PRISMA standards of quality for reporting systematic reviews and meta-analyses. The PICO methodology was utilised to formulate the research question (Table 1 ). The research question was as follows: 'Does using articaine LA provide superior pulpal and soft tissue anaesthetic efficacy in child patients receiving operative or extraction treatments when compared to lidocaine LA?'
Inclusion and exclusion criteria
An article was selected for inclusion in the review if it met the following criteria:
• Clinical trials involving human subjects who fall within the paediatric population (age <16 years), who were medically healthy and requiring routine dental treatment.
• Studies which provided original data generated by means of a comparative randomised controlled clinical trial design.
• Studies evaluating the anaesthetic effect of local anaesthetic solutions of articaine compared with lidocaine, using volumes of at least 1.0 mL per administration and in combination with a vasoconstrictor, as initial application.
• Studies evaluating interactions comparing local anaesthetic solutions of articaine with lidocaine, using volumes of at least 1.0 mL per administration, and in combination with a vasoconstrictor, for maxillary or mandibular infiltration or inferior dental nerve block.
• Studies that had a clearly defined the method for evaluating anaesthetic success, as well as detailed description of the techniques for administering the anaesthetic solution. The definition of anaesthetic success was that the patient would have described their pain levels as 'none' or 'mild' as measured using a standard visual analogue scale (VAS), WongBaker Facial Pain Scale (W-B FPS) or any equivalent pain scale validated to be used in children during clinical procedures. Letters to the editor, case reports, case-control or cohort studies, review articles and in vitro studies were excluded. Studies on computerised delivery routes and trials evaluating the less commonly used supplemental anaesthetic • Local anaesthesia, amid local anaesthetic.
• Dental, dentistry, dental anaesthesia.
• Articaine, carticaine, septocaine, septanest, ultracaine, thiophine, artikent, bartinest, and isonest.
• Primary dentition/teeth/tooth, primary dentition/teeth/tooth, baby tooth, baby teeth.
• Child, children, adolescent, young people, young person/s, young patient/s, preschool child/ren.
• Lignocaine, lidocaine, lignospan, lignospan special, xylocaine.
• Randomised control trial, control trial, control clinical trial A detailed systematic review protocol was developed and is available online on the international Prospective Register of Systematic Reviews (PROSPERO), which was approved and registered in the NHS Centre for Reviews and Dissemination (CRD) at the University of York (ref: CRD42013004620).
Data extraction and qualitative assessment
A standardised data extraction proforma were utilised to capture relevant data from included studies. This was carried out by two reviewers (FA and HJT). Risk of bias assessment was applied to both study methodology and outcome measures of all included studies. The quality assessment was analysed based on guidance suggested in Chapter 9 of the Cochrane Handbook of Systematic Reviews of Interventions 5.0.2. for assessing risk of bias of randomised controlled trials (RCTs). Two reviewers (HJT and MSD) independently evaluated the included studies. Additional input from a biostatistician (YFS) was also taken into consideration in the analysis. The risk bias evaluation was conducted based on the following domains: (1) random sequence generation, (2) allocation concealment, (3) blinding of participants and personnel, (4) blinding of outcome assessment, (5) incomplete outcome data, (6) selective reporting, and (7) other bias or potential threats to validity. Each domain was appraised to be of either 'high', 'unknown' or 'low' risk is bias. If all the seven domains were judged as 'low risk', the trial was considered as low risk of bias; if any domain was judged as 'unknown risk', the study was considered as 'moderate risk of bias'; if any domain was judged as 'high risk of bias', then the overall grade would be 'high risk of bias'. The information was collected using a standardised data collection proforma. In cases of disagreements, the overall risk of bias was resolved by consensus following discussions between the two reviewers.
Outcome measures and synthesis of results
The primary outcome measure analysed was pain ratings either by the patient, parental proxy or observer/investigator reported. The outcomes were recorded for definition of LA success, and whether pulpal, soft tissue anaesthesia or both parameters were evaluated. The extracted data were compared according to the timing of when the pain scale was administered, namely during procedure and after procedure. If a study reported pain score after injection, the result was categorised as pain score during procedure. If a study reported pain score on separate occasions, only pain scores reported during procedure and after procedure were extracted. Any validated pain scale used was acceptable for inclusion of a trial into this review. The secondary outcome measures evaluated included: adverse events, onset and duration of numbness, need for supplemental injections and vital signs and other physical parameters monitored.
In studies where the standard deviation (SD) was not reported directly, it was estimated from the standard error (SE). Both SD and SE were estimated according to the methods recommended in Cochrane Handbook of Systematic Reviews for Interventions 10 if the outcome measure was dichotomised and frequency was reported in the article. For cross-over trials, all measurements from intervention periods and controlled periods were analysed as if the trial were in a parallel group trial, which is a more conservative approach 10 . As a variety of self-reported pain scale was reported in the selected studies, all selfreported outcomes were summarised by calculating the Hedge's g standardised difference in means and corresponding 95% confidence interval. Hedge's g standardised difference in means transformed the study results to a common scale that facilitates pooling and it incorporates a small sample bias correction factor 11 . Random-effects model was used in the metaanalysis. Statistical heterogeneity was assessed across the studies using both I 2 statistics and chisquare test; I 2 statistics with values of 50% or greater was considered as showing substantial heterogeneity while threshold P-value <0.1 for chi-square 10 . Regardless of their risk of bias, all included studies were used in the primary analysis. In a sensitivity analysis, studies with high overall risk of bias were excluded to explore if the quality of included studies had any effect on the combined results.
Results

Search results
A total of 525 articles were identified in the initial search, and a repeated search in June 2017 identified a further five studies. Based on the inclusion/exclusion criteria, 22 articles were retrieved for full-text appraisal, following which 16 studies were excluded. Table 2 shows the reasons for exclusion of these studies. A total of six articles met the selection criteria and were included into the systematic review. The studies Malamed et al. in 2000 and 2001 12, 13 , which were published in both the Journal of the American Dental Association and Pediatric Dentistry was found to be related to the same study population and therefore analysed as a single study. The search and screening process are detailed in the PRISMA flowchart (Fig. 1) . 
Study characteristics
Design of included studies. Two of the six included studies were multicentre studies 12, 14 , with the rest being conducted as single centres studies (Table 3) . A cross-over design was utilised for three of six studies [14] [15] [16] . Only two studies compared LA given as infiltration anaesthesia against each other, whereas four studies compared Inferior Dental Nerve (IDN) block and infiltration anaesthesia in the same study.
Age range. The age range of subjects was wide across studies (range: 5-16 years), with all subjects being 16 years of age and younger. The reported mean ages were variable, of which three studies did not report the mean ages of subjects [16] [17] [18] . Drug volumes. The dosage and amounts of the two LA agents used were not uniform across studies. Only two studies compared equivalent concentrations of articaine and lidocaine 16, 19 , whereas the others had variable amounts administered to the child in which the maximum dose was calculated per body weight.
Treatment complexity. Simple treatment was defined as single extraction, routine operative treatment; and complex dental treatment being multiple extractions, multiple crowns and surgical procedures. Based on this definition, only two studies reported rendering complex treatment 14, 17 .
Analysis of outcome measures
Onset of anaesthesia. All included papers compared treatment outcomes at a patient level.
Only three studies reported evaluating onset time of anaesthesia, in which one study Fig. 1 . PRISMA flowchart summarising the systematic review process in identification of the included studies. categorised the onset time 14 , whereas two other studies reported the mean onset time 15, 16 . Methods for evaluation of onset time were mostly subjective evaluations by patients, with two studies evaluating the onset by asking the child when the sensation of soft tissue numbness started 14, 15 , and one paper 16 did not detail the method used for evaluation of anaesthesia onset. The delay in time for checking of anaesthesia onset varied between studies (from 2 to 5 min after LA delivery).
Adverse effects. Four of six studies evaluated the occurrence of adverse events 14, 15, 17, 19 . Among these, one study 19 reported not having any adverse events. Reports of post-operative complications included lip-biting, cheek biting, pain at injection site, tooth tenderness and episodes of aching jaw. These reported adverse effects were elicited largely through post-operative phone calls, and were patient reported with the help of the parents, or elicited directly from the parents. For the two studies that summarised the aforementioned minor adverse events 14, 17 , no significance differences were found in terms of risk of adverse events between lidocaine and articaine (RR = 1.10; 95% = 0.39 to 3.07; P-value = 0.863; Fig. 2b ). No evidence of heterogeneity was observed (I 2 = 0.0%; P-value for chi-square test = 0.835). One study 15 that reported on adverse events was excluded from the analysis as the information on the occurrence of adverse events in the experiment group was not adequately detailed.
Anaesthetic success and meta-analysis of pain ratings. Among the studies included in the review, evaluation of anaesthetic efficacy was largely carried out in the treatment phase of the study. Only two studies 14, 16 reported on patient's pain during the injection phase.
Patient self-reported pain during procedureBased on the data from three studies [14] [15] [16] , the Hedge's g standardised mean difference 0.06 (95% CI = À0.17 to 0.29; P-value = 0.614) from the random-effects meta-analysis demonstrated no difference in self-reported pain during procedure between lidocaine and articaine (Fig. 2a) . No evidence of heterogeneity was observed (I 2 = 0.0%; P-value for chisquare test = 0.809).
Patient self-reported pain after procedure-Based on the data from four studies 14, [17] [18] [19] , the Hedge's g standardised mean difference 0.37 (95% CI = 0.08 to 0.67; P-value = 0.013) indicated that articaine was better than lidocaine in reducing pain intensity after procedure (Fig. 2a) . As I 2 is <50% and P-value for chi-square test is above the threshold 0.1, low evidence of substantial heterogeneity was observed (I 2 = 44.1%; P-value for chi-square test = 0.147).
Risk bias and quality assessment. Both visual inspection of funnel plot (Fig. 3 ) and Egger's test suggested no publication bias was detected for self-reported pain after procedure and adverse events. Yet, Egger's test demonstrated likelihood of publication bias in self-reported pain during procedure (P-value = 0.015). Among the included studies, only one study had low risk of bias, whereas three studies had high risk of bias, and two studies had moderate/ uncertain risk of bias. Therefore, the overall risk of bias across studies was deemed to be high. Figure 4 shows the risk bias summaries of evaluated categories in each included study. Sensitivity analysis was performed to evaluate the impact of studies with high overall risk of bias. Even when excluding the studies with high overall risk of bias, patients who received articaine injections reported significantly less pain after procedure (P-value = 0.016; Fig. 3b ).
Discussion
Pain control is paramount in the reduction of dental procedure related fear and anxiety. As such, efficacious LA agents couple with good behaviour management skills and operator proficiency remains the backbone of anxiety control and henceforth treatment success in young paediatric patients.
In this review, it was found that a range of LA volumes was administered across studies. Yet, these volumes were assessed equally as they were deemed to be clinically equitable amounts which would produce adequate anaesthesia for the treatment procedures evaluated. Only two studies directly compared equivalent concentrations of articaine hydrochloride and lidocaine hydrochloride 16, 19 . Furthermore, the need for supplemental injections was evaluated in two studies 14, 16 . The necessity for top up of LA solutions intra-operatively, which was not always in the same patient, was found to be required for both articaine and lidocaine treatment groups. This therefore suggests equal inability of both anaesthetic agents to achieve profound anaesthesia with the amounts given, and therefore reflecting possible inadequate LA delivered for the clinical requirement of the condition/procedure. In view of this, the volume difference between the LA delivered and the extent of its impact on individual clinical outcomes cannot reliably be determined.
Apart from comparisons of different concentrations of LAs, this review also included studies which utilised different methods for delivering LA, namely infiltration and IDN block. Additionally, the tooth selection method for anaesthetic evaluation varied greatly among studies, as were the number of teeth evaluated per experimental administration. Both infiltration and block anaesthesia are the two most common local anaesthetic delivery methods in clinical dentistry 1 , and both routes of administration were considered within the scope of this review. The efficacy of local anaesthetic solutions was evaluated in scenarios where it was given as a combination of both techniques, that is local infiltration as well as IDN block anaesthesia.
Nerve blocks have been shown to be more painful than infiltration technique due to the higher volume, longer duration of injection and penetrance of needle into multiple deeper structures 20 . On the other hand, infiltration anaesthesia is perceived to be less technique sensitive, and possibly also less painful during administration. It is, however, interesting to note that two studies in this review conversely showed more crying during infiltration than block anaesthesia 14, 15 . The study by Arrow (2012) 15 reported a 100% clinician judgement of LA success with IDN block and 68% with infiltration, which was attributed to the level of clinical experience of the performing dentists and frequent use of the IDN block technique compared to infiltration in treating mandibular posterior teeth in young patients. Although it can be argued that some operators will be more skilled than others at delivering IDN block to either side of the jaw, it should be noted that the extent of the effect of intra-operator variability or performance bias remains uncertain and cannot be evaluated within the scope of this review. Moreover, it should be highlighted that majority of studies did not evaluate patients' pain perception during LA delivery, and only evaluated pain experienced during the procedure, and this would be interesting to evaluate in the design of future studies.
Noteworthy is that all studies in this review utilised infiltration for administration of articaine, with the route of administration for articaine being largely pre-determined by the fact that articaine is not recommended for use as block anaesthesia in children in some countries. Studies have shown that regardless of whether articaine or lignocaine is administered, infiltration anaesthesia appears to be successful in up to 100% of cases in the maxilla 21 . Yet, this was different for the posterior mandible, where articaine success rates were found to be inconsistent 22 . Yet, these studies were carried out in adults, and the results may not be applicable to children as it is believed that the maxillary bone progressively becomes sclerotic with age, and therefore, in young patients, there is enhanced vestibule-palatal diffusion of articaine. The ability of articaine to anaesthetise palatal tissues in a single buccal infiltration injection was evaluated in two studies 18, 19 . Despite delivering similar quantities of LA in both studies, the studies had contradictory outcomes with one study 19 reporting successful maxillary primary molar extractions procedures using articaine LA bypassing palatal injections, and none of the groups were found to be able to achieve adequate palatal anaesthesia with buccal infiltration in the other 18 . Therefore, more future studies on the ability of articaine to achieve profound anaesthesia with buccal infiltration alone are required in order to reach a more definite conclusion on this.
In terms of safety and patient reported outcomes following the procedure, the meta-analysis conducted found no difference between the groups. Adverse events were reported in four of six included studies. It should be highlighted that adverse events were not clinically verified but instead commonly self-reported by patients with the help of their parents, or by parents by means of a post-operative phone call, thus predisposing it to some degree of bias. That being said, these reported adverse events were generally minor, with no reports of paraesthesia. Although there were reports of mild allergic type reactions (e.g., rash or pruritis) among studies evaluated, more severe reactions such as oedema, urticaria, erythema and anaphylactic shocks were not reported in any of the included studies. Additionally, it would be likely that those allergic to articaine would also respond similarly to other amide-based local anaesthetic agents including lignocaine 17 . However, it should be noted that healthy children with reduced risk of having complications associated with local anaesthesia were enrolled in these studies. Consequently, it is not possible to ascertain the risk of either local anaesthetic agent on child patients with other comorbidities.
Additionally, articaine was found to be more superior in terms of reducing pain intensity post-procedure, which remained unchanged even following sensitivity analysis in which studies with high overall risk of bias were excluded. Articaine was also found to have longer lasting effect on soft tissue numbness in some studies. Alongside this comes the concern of prolonged numbness following articaine use 23 , which can lead to other undesirable outcomes such as lip and cheek biting in children. This, while reported in some children, was neither found to be of a high number nor was it raised as a substantial concern among the included studies.
The main approaches for all reviewed studies in determining anaesthetic efficacy were through patient reported pain experienced Overall risk across studies: HIGH during the procedure, with the patient rating pain using a pain scale instrument during dental treatments. As a variety of selfreported pain scale was reported in the selected studies, all self-reported outcomes were summarised by calculating the Hedge's g standardised difference in means and corresponding 95% confidence interval. Hedge's g standardised difference in means transformed the study results to a common scale that facilitates pooling and it incorporates a small sample bias correction factor 11 . It must be mentioned, however, that the overall reporting for local anaesthetic onset was found to be inadequately addressed in the studies included in the review. The authors were not able to analyse onset time of articaine compared with lidocaine, as only two studies reported onset time while one of the them categorised the onset time instead of reporting the mean and SD. Additionally, it was noted that onset of anaesthesia was often reported as the child's subjective report of soft tissue symptoms, and signs of soft tissue analgesia were carried out at a certain time point after completion of anaesthetic administration. Some studies also reported LA success being determined by clinicians using clinical evaluation methods, for example patient reaction and feedback to tactile evaluation for soft tissue analgesia, as well as patient report of pain following commencement of treatment. These subjective methods may not be completely reliable as the presence of soft tissue anaesthesia may not be accurately reflective of having achieved profound pulpal anaesthesia, and more objective measurements methods are recommended to be undertaken instead 24 . Suggested methods in the literature for confirmation of anaesthesia include the use of Electric Pulp Tester (EPT) at 60-s periodicities 25 or thermal tests using cold stimuli 26 , which has been reported for use in several local anaesthesia studies but has been criticised for not being able to guarantee pulpal anaesthesia in clinical scenarios such as irreversible pulpitis 27 . Future studies should therefore look into more objective methods for assessment of anaesthesia onset in their study designs.
This systematic review mainly aimed to provide a comprehensive and current overview of the existing evidence on local anaesthetic solutions (lidocaine/articaine) effectiveness in paediatric clinical dentistry. Appropriate methodology for random allocation, blinding, allocation concealment and patient follow-up affects the internal validity of an RCT.Trials with poor or inadequately reported methodology have been shown to exaggerate treatment effects 28 . In view of this, concerted efforts were made to locate all clinical studies which were relevant in hope of comprehensively investigating, and comparing these two anaesthetic agents. Despite this, methodological inconsistencies and differential reporting of outcome measures with potentially high risk of bias were noted among majority of the six included studies.
Although it was noted that three of six studies had attempted to reduce inter-operator variability by having a single operator administer the local anaesthesia for all patients enrolled in the study 16, 18, 19 , the possibility of potential effects of clinical heterogeneity within and between studies cannot be fully excluded, nor avoided in a review of this nature. Finally, the authors found substantial heterogeneity in the reporting of outcomes among studies, which has made comparison and synthesis of outcomes difficult. This review calls for more rigorous methodologies to be employed in the design and implementation of future clinical trials, including better standardisation of reporting outcomes and in order to achieve better-quality comparability between studies.
Conclusions
Considering the present findings, the quality of RCTs which were included in this review was generally inadequate with high risk of bias. Hence, there is low quality evidence suggesting that both articaine as infiltration and lidocaine IAD nerve blocks presented the same efficacy when used for routine dental treatments. There is low quality evidence suggesting no difference between patient selfreported pain between articaine and lidocaine during treatment procedures. Yet, there appears to be significantly less patient reported pain post-procedure following articaine injections. There was no difference in the occurrence of adverse events between articaine and lidocaine injections following treatment in paediatric patients.
Why this paper is important to paediatric dentists • Both articaine as infiltration and lidocaine IAD nerve blocks presented the same efficacy when used for routine dental treatments; however, patients reported less pain post-procedure following articaine injections.
• The occurrence of adverse events post-operatively was found to be similarly low when comparing between articaine and lidocaine injections following treatment in paediatric patients; therefore, articaine is equally safe for use in paediatric patients.
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